Stock listing
Phathom Pharmaceuticals, Inc.
Selected listing: PHAT · NASDAQ · USD · US
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), Health Technology. Latest release Sep 29, 2026: Phathom Pharmaceuticals Announces Initiation of Registrational…
- Ticker
- NASDAQ:PHAT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. is a public company traded under the ticker PHAT in the American market. Phathom focuses on developing innovative treatments for gastrointestinal diseases.
Latest news from Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
September 29, 2026
Phathom Pharmaceuticals Announces Initiation of Registrational Phase 3 Study of VOQUEZNA® (vonoprazan) for As-Needed Treatment of Non-Erosive GERD
September 28, 2026
Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
July 30, 2026
Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026
July 20, 2026
Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
June 23, 2026
Events
Research Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. company profile
View the public company page for Phathom Pharmaceuticals, Inc. on 6ix.
Phathom Pharmaceuticals, Inc. news
Read company news and market updates connected to Phathom Pharmaceuticals, Inc..
Phathom Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Phathom Pharmaceuticals, Inc..